Equities

Bayer AG

0P6S:LSE

Bayer AG

  • Price (EUR)29.26
  • Today's Change-0.7675 / -2.62%
  • Shares traded421.33k
  • 1 Year change-45.58%
  • Beta--
Data delayed at least 20 minutes, as of May 16 2024 17:35 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Bayer AG's revenues fell -6.11% from 50.74bn to 47.64bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 4.15bn to a loss of 2.94bn.
Gross margin58.57%
Net profit margin-6.64%
Operating margin1.55%
Return on assets-2.55%
Return on equity-8.16%
Return on investment-3.48%
More ▼

Cash flow in EURView more

In 2023, Bayer AG increased its cash reserves by 14.23%, or 736.00m. The company earned 5.12bn from its operations for a Cash Flow Margin of 10.74%. In addition the company used 3.52bn on investing activities and also paid 679.00m in financing cash flows.
Cash flow per share7.46
Price/Cash flow per share3.93
Book value per share36.24
Tangible book value per share-20.87
More ▼

Balance sheet in EURView more

Bayer AG has a Debt to Total Capital ratio of 56.40%, a lower figure than the previous year's 82.15%.
Current ratio1.31
Quick ratio0.8727
Total debt/total equity1.30
Total debt/total capital0.564
More ▼

Growth rates in EUR

SmartText is unavailable
Div yield(5 year avg)3.51%
Div growth rate (5 year)-47.66%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-202.70
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.